Latest Pfizer News
Comprehensive Pfizer Stock Updates: Catch up on the latest Pfizer stock news and industry insights. Get quick details on Pfizer stock buybacks,Pfizer results, Pfizer company analysis, Pfizer live prices, Pfizer dividends, Pfizer bonus share, board meetings, lifetime highs, Pfizer targets, lows, and growth stories with AI.
Business Line
Pfizer launches ‘Analytics Gateway’ in India, its first dedicated global commercial analytics centre
The centre is expected to accelerate data science and AI solutions to meet Pfizer’s ambitions in modernising marketing and creating an agile sales force
•
Wed, Sep 18, 2024
The Economic Times
Pfizer sets up analytics capability centre in Mumbai
Pfizer has launched its first dedicated commercial analytics centre in Mumbai, named 'the Analytics Gateway'. This centre will support Pfizer's international markets by providing data and analytics insights to benefit patients. It aims to modernize marketing, create an agile sales force, and enhance commercial effectiveness globally.
•
Wed, Sep 18, 2024
Hindustan Times
Pfizer drug helped cancer patients regain lost weight, study shows
Pfizer’s experimental cancer weight loss drug helped patients regain weight in a mid-stage study giving fresh promise for the dangerous muscle-wasting condition
•
Sun, Sep 15, 2024
The Economic Times
AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fight
On Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $107.5 million award against AstraZeneca. Pfizer had claimed AstraZeneca's Tagrisso infringed these patents. Judge Kennelly's ruling found the patents lacked sufficient written descriptions and were not reproducible by a skilled scientist. This decision dismisses the damages awarded in May and affects Pfizer’s ongoing patent infringement claims. The case, Wyeth LLC v. AstraZeneca Pharmaceuticals LP, was heard in the District of Delaware.
•
Wed, Aug 14, 2024
